Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gilead Sciences, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GILD
Nasdaq
2830
www.gilead.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gilead Sciences, Inc.
BMY vs GILD: Which Biotech Stock Looks More Attractive Now?
- Sep 21st, 2026 9:55 am
Novo Nordisk Stock Drops 5.6% as 2030 Goals Match Peers
- Sep 21st, 2026 6:20 am
Why Morgan Stanley likes Gilead's HIV prevention play
- Sep 20th, 2026 10:03 am
Why Is Gilead Sciences (GILD) Widening Lenacapavir Access Across 120 Countries?
- Sep 19th, 2026 10:17 pm
Gilead Strengthens HIV Growth Platform with Expanded Latin America Access
- Sep 18th, 2026 10:51 am
4 Biotech Stocks to Watch as Potential Takeover Targets
- Sep 18th, 2026 10:31 am
J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
- Sep 18th, 2026 7:05 am
Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF
- Sep 17th, 2026 4:36 pm
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
- Sep 17th, 2026 7:00 am
Gilead Expands Lenacapavir Access With New PAHO Deal in Latin America
- Sep 16th, 2026 8:26 am
Gilead Expands Lenacapavir Licensing Agreements to Include Once-Yearly HIV Prevention Formulation
- Sep 16th, 2026 7:46 am
Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention
- Sep 16th, 2026 6:30 am
Sector Update: Healthcare Stocks Ease Late Afternoon
- Sep 15th, 2026 1:52 pm
Gilead Sciences Sees Yeztugo Powering HIV Growth as Oncology Pipeline Advances
- Sep 15th, 2026 12:02 pm
Sector Update: Healthcare Stocks Lower Tuesday Afternoon
- Sep 15th, 2026 11:44 am
Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean
- Sep 15th, 2026 9:10 am
Gilead Sciences Inc's Dividend Analysis
- Sep 15th, 2026 5:01 am
Is Gilead Sciences (GILD) Reasonable Given Its Sales Base?
- Sep 14th, 2026 5:19 pm
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
- Sep 14th, 2026 4:00 pm
Scroll